Home » Stocks » Misonix

Misonix, Inc. (MSON)

Stock Price: $14.20 USD -0.07 (-0.49%)
Updated Aug 13, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 246.54M
Revenue (ttm) 58.52M
Net Income (ttm) -11.23M
Shares Out 17.36M
EPS (ttm) -0.88
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 13, 2020
Last Price $14.20
Previous Close $14.27
Change ($) -0.07
Change (%) -0.49%
Day's Open 14.14
Day's Range 14.00 - 14.29
Day's Volume 24,350
52-Week Range 6.71 - 22.44

More Stats

Market Cap 246.54M
Enterprise Value 248.01M
Earnings Date (est) Sep 3, 2020
Ex-Dividend Date n/a
Shares Outstanding 17.36M
Float 11.85M
EPS (basic) -0.73
EPS (diluted) -0.88
FCF / Share -1.37
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 602,702
Short Ratio 7.56
Short % of Float 5.59%
Beta 1.20
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 4.21
PB Ratio 1.60
Revenue 58.52M
Operating Income -14.20M
Net Income -11.23M
Free Cash Flow -22.79M
Net Cash -1.48M
Net Cash / Share -0.09
Gross Margin 46.61%
Operating Margin -24.26%
Profit Margin -19.20%
FCF Margin -38.95%
ROA -5.81%
ROE -12.60%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$21.00*
(47.89% upside)
Low
18.0
Current: $14.20
High
23.0
Target: 21.00
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue38.8536.6827.2723.1122.2017.0614.8315.6812.3713.37
Revenue Growth5.91%34.51%17.98%4.09%30.15%15.06%-5.43%26.71%-7.47%-
Gross Profit27.2826.8819.0515.4714.9211.137.409.217.096.53
Operating Income-7.41-2.94-6.60-5.83-1.71-2.55-5.32-1.49-2.73-3.96
Net Income-7.39-7.61-1.68-1.175.571.39-2.670.37-3.53-2.86
Shares Outstanding9.339.018.407.787.587.237.057.007.007.00
Earnings Per Share-0.79-0.87-0.22-0.170.690.19-0.380.05-0.50-0.41
EPS Growth----263.16%-----
Operating Cash Flow-3.68-0.56-1.27-0.320.020.70-0.47-1.42-0.99-0.81
Capital Expenditures-0.68-0.38-0.49-0.47--0.07-0.53-0.47-0.64-1.05
Free Cash Flow-4.37-0.94-1.76-0.790.020.63-1.00-1.89-1.64-1.86
Cash & Equivalents7.8410.9811.569.059.627.045.816.477.0910.98
Total Debt---------0.19
Net Cash / Debt7.8410.9811.569.059.627.045.816.477.0910.78
Assets29.9529.0233.3727.7326.4519.5317.3618.3118.3620.46
Liabilities8.254.625.233.332.703.183.582.723.482.33
Book Value21.7024.4028.1424.4023.7516.3513.7815.5914.8818.13
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Misonix, Inc.
Country United States
Employees 125
CEO Stavros G. Vizirgianakis

Stock Information

Ticker Symbol MSON
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: MSON
IPO Date January 23, 1992

Description

Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.